Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Its portfolio includes treatments for cardiovascular, oncology, hematology, immunology, and fibrotic diseases.
Bristol-Myers Squibb Company operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for BMY.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). BMY Stock Intelligence Report. [stoxpulse.com/stocks/bmy]
Disclaimer: The information on this page about Bristol-Myers Squibb Company (BMY) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Bristol-Myers Squibb Company.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 10%
Mar 31
Haller bought 20K shares
Jun 15
Short bought 8K shares
Jun 3
AbbVie Stock Zigs When The Market Zags
1h ago
What to Watch in Pfizer's Non-Oncology Portfolio T...
6h ago
StoxPulse AI results for BMY: Pulse Score 49/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$122.85B
P/E Ratio
15.6
EPS
$0.53
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+35.0%
Sep 25
+6.9%
Dec 25
+11.9%
Mar 26
+10.4%
Beat estimates 4 of 4 quarters (100%)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Its portfolio includes treatments for cardiovascular, oncology, hematology, immunology, and fibrotic diseases.
AbbVie Stock Zigs When The Market Zags
What to Watch in Pfizer's Non-Oncology Portfolio This Earnings Season
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
Bristol Myers Expands NVIDIA Partnership to Build Top Life Sciences AI Supercomputer
Sector Update: Healthcare Stocks Fall Late Afternoon
Bristol Myers Squibb expands NVIDIA AI supercomputer for drug discovery
Top Midday Stories: Brookfield, CPP Investments to Acquire LXP; Google Working on New Server Chip
Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery